Department of Neurosurgery, University Medical Center Göttingen, Robert-Koch-Straße 40, Göttingen, 37075, Germany.
Department of Physiology and Pharmacology, Georgetown University, 3900 Reservoir Rd NW, Washington, DC, 2007, USA.
Eur J Trauma Emerg Surg. 2024 Oct;50(5):2491-2499. doi: 10.1007/s00068-024-02604-w. Epub 2024 Jul 25.
The precision of assessment and prognosis in traumatic brain injury (TBI) is paramount for effective triage and informed therapeutic strategies. While the Glasgow Coma Scale (GCS) remains the cornerstone for TBI evaluation, it overlooks critical primary imaging findings. The Helsinki Score (HS), a novel tool designed to incorporate radiological data, offers a promising approach to predicting TBI outcomes. This study aims to evaluate the prognostic efficacy of HS in comparison to GCS across a substantial TBI patient cohort.
This retrospective study encompassed TBI patients treated at our institution between 2008 and 2019, specifically those with an admission GCS of 14 or lower. We assessed both the initial GCS and the HS derived from primary CT scans. Key outcome metrics included the Glasgow Outcome Scale (GOS) and mortality rates at hospital discharge and at 6 and 12-month intervals post-discharge. Predictive performances of GCS and HS were analyzed through Receiver Operating Characteristic (ROC) curves and Kendall tau-b correlation coefficients against each outcome.
The study included 544 patients, with an average age of 62.2 ± 21.5 years, median initial GCS of 14, and a median HS of 3. The mortality rate at discharge stood at 8.6%, with a median GOS of 4. Both GCS and HS demonstrated significant correlations with mortality and GOS outcomes (p < 0.05). Notably, HS showed a markedly superior correlation with mortality (τb = 0.36) compared to GCS (τb = -0.11) and with GOS outcomes (τb = -0.40 for HS vs. τb = 0.33 for GCS). ROC analyses affirmed HS's enhanced predictive accuracy over GCS for both mortality (AUC of 0.79 for HS vs. 0.62 for GCS) and overall outcomes (AUC of 0.77 for HS vs. 0.71 for GCS).
The findings validate the HS in a large German cohort and suggest that radiological assessments alone, as exemplified by HS, can surpass the traditional GCS in predicting TBI outcomes. However, the HS, despite its efficacy, lacks the integration of clinical evaluation, a vital component in TBI management. This underscores the necessity for a holistic approach that amalgamates both radiological and clinical insights for a more comprehensive and accurate prognostication in TBI care.
在创伤性脑损伤(TBI)中,评估和预后的精确性至关重要,这对于有效的分诊和知情的治疗策略至关重要。格拉斯哥昏迷评分(GCS)仍然是 TBI 评估的基石,但它忽略了关键的原发性影像学发现。赫尔辛基评分(HS)是一种新的工具,旨在纳入放射学数据,为预测 TBI 结果提供了一种有前途的方法。本研究旨在评估 HS 在与 GCS 相比时在大量 TBI 患者中的预后效果。
本回顾性研究包括 2008 年至 2019 年在我院治疗的 TBI 患者,具体为入院时 GCS 为 14 或更低的患者。我们评估了初始 GCS 和源自初级 CT 扫描的 HS。主要结局指标包括格拉斯哥结局量表(GOS)和出院时以及出院后 6 个月和 12 个月的死亡率。通过接收者操作特征(ROC)曲线和 Kendall tau-b 相关系数分析 GCS 和 HS 对每个结局的预测性能。
该研究纳入了 544 名患者,平均年龄为 62.2±21.5 岁,初始 GCS 中位数为 14,HS 中位数为 3。出院时的死亡率为 8.6%,中位 GOS 为 4。GCS 和 HS 均与死亡率和 GOS 结局显著相关(p<0.05)。值得注意的是,HS 与死亡率的相关性明显优于 GCS(tau-b=0.36 比 tau-b=-0.11),与 GOS 结局的相关性也明显优于 GCS(tau-b=0.40 比 tau-b=0.33)。ROC 分析证实,HS 在死亡率(HS 的 AUC 为 0.79,GCS 的 AUC 为 0.62)和总体结局(HS 的 AUC 为 0.77,GCS 的 AUC 为 0.71)方面均优于 GCS。
该研究结果在一个大型德国队列中验证了 HS 的有效性,并表明仅进行放射学评估(如 HS 所示)就可以优于传统的 GCS 来预测 TBI 结局。然而,尽管 HS 有效,但它缺乏临床评估的整合,这是 TBI 管理中的一个重要组成部分。这突显了需要采取整体方法,将放射学和临床见解相结合,以在 TBI 护理中进行更全面和准确的预后预测。